Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1615-2573

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists ; day:21 ; month:1 ; year:2022 ; pages:1-10
Heart and vessels ; (21.1.2022), 1-10

Creator: Sakai, Takahiro
Motoki, Hirohiko
Fuchida, Aya
Takeuchi, Takahiro
Otagiri, Kyuhachi
Kanai, Masafumi
Kimura, Kazuhiro
Minamisawa, Masatoshi
Yoshie, Koji
Saigusa, Tatsuya
Ebisawa, Soichiro
Okada, Ayako
Kitabayashi, Hiroshi
Kuwahara, Koichiro

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00380-022-02027-w

URN: urn:nbn:de:101:1-2022050223120253276490

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Sakai, Takahiro
Motoki, Hirohiko
Fuchida, Aya
Takeuchi, Takahiro
Otagiri, Kyuhachi
Kanai, Masafumi
Kimura, Kazuhiro
Minamisawa, Masatoshi
Yoshie, Koji
Saigusa, Tatsuya
Ebisawa, Soichiro
Okada, Ayako
Kitabayashi, Hiroshi
Kuwahara, Koichiro
SpringerLink (Online service)

Other Objects (12)

New Anticoagulants for Atrial Fibrillation

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

New Anticoagulants for Atrial Fibrillation

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

New Anticoagulants for Atrial Fibrillation

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

New Anticoagulants for Atrial Fibrillation

New Anticoagulants for Atrial Fibrillation

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

New Anticoagulants for Atrial Fibrillation

New Anticoagulants for Atrial Fibrillation

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

New Anticoagulants for Atrial Fibrillation

New Anticoagulants for Atrial Fibrillation

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

Related objects

Reset password